Make a Difference with a Donation

The CURED Mission

CURED is a not for profit foundation dedicated to those suffering from Eosinophilic Gastrointestinal Diseases (EGID), including eosinophilic esophagitis (EoE), eosinophilic gastritis (EG), eosinophilic colitis (EC) and other eosinophilic disorders.

CURED is committed to raising substantial funding to aid in research, advocating on behalf of EGID patients and their families, and working to educate and increase awareness about this complex group of diseases. It is our heartfelt belief that CURED can make a difference for the individuals and their families who are touched by these diseases.



Fast Facts about COVID -19 & EGIDs from Dr. Marc Rothenburg

  • We do not have substantial data about COVID-19 and EGID.
  • We do know that EGID is not an immune-deficiency disease.
  • There is no known risk for viral infections in EGID patients.
  • Patients on eosinophil depleting drugs such as benralizumab and patients with eosinophilia have not been reported to have an increased risk of viral infections and/or complications from viral infections, indicating that eosinophil dysregulation (increased or decreased levels) is not a primary response against viruses.
    Fluticasone and Budesonide are not systemic steroid medications, and therefore there’s no immune suppression.

A caveat to this information concerns rare EGID patients that may have another underlying disease or EGID patients on systemic steroids; these patients may have some increased risk for complications.   Such patients should consult with their primary doctor for specific advice and guidance.
Patients with concerns should contact their health provider on a case by case basis. This is still a very fluid situation.
Also check and

In view of the evolving COVID-19 infection, we advise patients and their families to follow the CDC’s reccommendations for travel, preventative measures and preparedness at Stay updated with your state and local health department’s advisories for your area.

provided by CURED Medical Advisory Board Member

Marc E. Rothenberg MD, PhD

Professor of Pediatrics

Bunning Chair of Allergy and Immunology

Director, Division of Allergy and Immunology

Director, Cincinnati Center for Eosinophilic Disorders

Cincinnati Children’s Hospital Medical Center


A message from CEGIR

Cured Foundation

Subscribe to the CURED E-Mail List

New Patient Contact Registry for Rare Eosinophilic Gastrointestinal Diseases


CURED has donated over $5 Million to research being done at Cincinnati Children’s Hospital, Denver Children’s Hospital, Northwestern University, University of Illinois at Chicago, University of North Carolina School of Medicine (Chapel Hill, NC), Ann & Robert Lurie Children’s Hospital (Chicago, IL), and University of Utah, Brigham and Women’s Hospital

Apply for a research grant!

CURED provides grants support to new and established investigators performing clinical research in any area that is relevant to the etiology or pathophysiology of eosinophilic esophagitis, eosinophilic gastroenteritis, eosinophilic colitis and other eosinophilic disorders. If you are interested in applying for a grant from CURED, please contact

SSL Certificate security seal